Further, the public data from the Kaplan–Meier plotter indicate that high gene expression of EGFR, mTOR, MAPK, and ERK1/2 is positively associated with shorter relapse−free survival (RFS) in ER−negative breast cancer patients (Figure S6A–D). Here, EGFR is linked to breast carcinoma.